Literature DB >> 19159436

Effects of niacin on cell adhesion and early atherogenesis: biochemical and functional findings in endothelial cells.

Subramaniam Tavintharan1, Su Chi Lim, Chee Fang Sum.   

Abstract

Atherosclerotic cardiovascular disease is a major cause of morbidity and mortality. Increased expression of cell adhesion molecules (CAM) and their ligands mediate essential processes in atherogenesis. Niacin reduces atherosclerotic cardiovascular complications and total mortality. Further understanding is needed on effects of niacin on CAM, and its functional consequences. The aim of this study was to evaluate the effects of niacin on CAM expression and monocyte adhesion in endothelial cells. Endothelial cells (HUVEC) were cultured to reach 80-90% confluence before experiments were initiated. Cells were exposed to DME/F12 with selected concentrations of niacin. To elicit the expression of CAM, cells were stimulated by addition of tumour necrosis factor (TNF)-alpha, interleukin (IL)-1 or interferon-gamma. Lysate from the conditioned media was assayed for CAM. The effect of niacin on mRNA expression of ICAM-1 was studied using semi-quantitative analysis of ICAM-1 mRNA. Adhesion assays were performed with flow cytometry to study the functional significance of the effects niacin on CAM expression. Niacin significantly reduced ICAM-1 and PECAM-1 protein levels basally, and reduced the cytokine-induced rise in ICAM-1, with a similar effect for TNF-alpha-induced PECAM-1 rise. The decrease in TNF-alpha-induced rise in ICAM-1 level was associated with a reduction of NF-kappaB activation, a reduction in mRNA expression of ICAM-1, and a functional reduction in monocyte adhesion to cultured endothelial cells. Niacin reduces CAM expression and monocyte adhesion to endothelial cells. Apart from its lipid-modifying effects, these pleiotropic effects of niacin may potentially contribute to the beneficial effects of risk reduction for atherosclerotic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19159436     DOI: 10.1111/j.1742-7843.2008.00364.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  8 in total

Review 1.  Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.

Authors:  Insug Kang; Sang-Wook Kim; Jang H Youn
Journal:  J Clin Endocrinol Metab       Date:  2011-08-03       Impact factor: 5.958

Review 2.  Niacin in cardiovascular disease: recent preclinical and clinical developments.

Authors:  Janet E Digby; Neil Ruparelia; Robin P Choudhury
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

3.  Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.

Authors:  Martina Lukasova; Camille Malaval; Andreas Gille; Jukka Kero; Stefan Offermanns
Journal:  J Clin Invest       Date:  2011-02-07       Impact factor: 14.808

4.  Tunable leuko-polymersomes that adhere specifically to inflammatory markers.

Authors:  Gregory P Robbins; Randi L Saunders; Jered B Haun; Jeff Rawson; Michael J Therien; Daniel A Hammer
Journal:  Langmuir       Date:  2010-09-07       Impact factor: 3.882

5.  Niacin Promotes Cardiac Healing after Myocardial Infarction through Activation of the Myeloid Prostaglandin D2 Receptor Subtype 1.

Authors:  Deping Kong; Juanjuan Li; Yujun Shen; Guizhu Liu; Shengkai Zuo; Bo Tao; Yong Ji; Ankang Lu; Michael Lazarus; Richard M Breyer; Ying Yu
Journal:  J Pharmacol Exp Ther       Date:  2017-01-05       Impact factor: 4.030

6.  Niacin inhibits carrageenan-induced neutrophil migration in mice.

Authors:  Raphael Gomes Ferreira; Tamires Cardoso Matsui; Lindisley Ferreira Gomides; Adriana Martins Godin; Gustavo Batista Menezes; Márcio de Matos Coelho; André Klein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-26       Impact factor: 3.000

Review 7.  Niacin, an old drug with a new twist.

Authors:  Wen-Liang Song; Garret A FitzGerald
Journal:  J Lipid Res       Date:  2013-08-15       Impact factor: 5.922

Review 8.  GPR109A and vascular inflammation.

Authors:  Joshua T Chai; Janet E Digby; Robin P Choudhury
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.